Kidney Neoplasms
84
11
14
38
Key Insights
Highlights
Success Rate
70% trial completion
Published Results
17 trials with published results (20%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
19.0%
16 terminated out of 84 trials
70.4%
-16.2% vs benchmark
11%
9 trials in Phase 3/4
45%
17 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 38 completed trials
Clinical Trials (84)
HTL0039732 in Participants With Advanced Solid Tumours
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers
The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment
Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
Savolitinib vs. Sunitinib in MET-driven PRCC.
Multimodal Prediction of Postoperative Prognosis After Partial Nephrectomy for Endophytic Renal Cell Carcinoma
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
CD70-targeted immunoPET Imaging of Kidney Cancer
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy
A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India